Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Laterality and Stimulation Bias in Meta-analysis of Placebo Responses

Laterality and Stimulation Bias in Meta-analysis of Placebo Responses Letters 5. Damoiseaux J, Vulsteke J-B, Tseng C-W, et al. Autoantibodies in idiopathic already demonstrated different sensitivity and specificity 5 inflammatory myopathies: clinical associations and laboratory evaluation by between immunoassays. In addition, up to 10% of healthy mono- and multispecific immunoassays [published online January 11, 2019]. controls have a positive result for MSA using commercial Autoimmun Rev. doi:10.1016/j.autrev.2018.10.004 immunoassays. This suggests the possibility of false-positive 6. Rantapää-Dahlqvist S, de Jong BAW, Berglin E, et al. Antibodies against cyclic results or that MSA can appear before the onset of myositis as, citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48(10):2741-2749. doi:10.1002/art.11223 for example, antibodies against cyclic citrullinated peptide predict the development of rheumatoid arthritis. To answer these points, international efforts are now in progress to try to Laterality and Stimulation Bias in Meta-analysis harmonize the detection of MSA. In addition to the character- of Placebo Responses istics of the detection tests that will be used (eg, antigen sources, To the Editor Zunhammer et al claim that the effects of pla- method of detection, or positivity threshold) another point that cebo are small in terms of changes in bottom-up nociceptive must be considered is the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Neurology American Medical Association

Laterality and Stimulation Bias in Meta-analysis of Placebo Responses

JAMA Neurology , Volume 76 (7) – Jul 20, 2019

Loading next page...
 
/lp/american-medical-association/laterality-and-stimulation-bias-in-meta-analysis-of-placebo-responses-x6CNVNJes1
Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
2168-6149
eISSN
2168-6157
DOI
10.1001/jamaneurol.2019.1229
Publisher site
See Article on Publisher Site

Abstract

Letters 5. Damoiseaux J, Vulsteke J-B, Tseng C-W, et al. Autoantibodies in idiopathic already demonstrated different sensitivity and specificity 5 inflammatory myopathies: clinical associations and laboratory evaluation by between immunoassays. In addition, up to 10% of healthy mono- and multispecific immunoassays [published online January 11, 2019]. controls have a positive result for MSA using commercial Autoimmun Rev. doi:10.1016/j.autrev.2018.10.004 immunoassays. This suggests the possibility of false-positive 6. Rantapää-Dahlqvist S, de Jong BAW, Berglin E, et al. Antibodies against cyclic results or that MSA can appear before the onset of myositis as, citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48(10):2741-2749. doi:10.1002/art.11223 for example, antibodies against cyclic citrullinated peptide predict the development of rheumatoid arthritis. To answer these points, international efforts are now in progress to try to Laterality and Stimulation Bias in Meta-analysis harmonize the detection of MSA. In addition to the character- of Placebo Responses istics of the detection tests that will be used (eg, antigen sources, To the Editor Zunhammer et al claim that the effects of pla- method of detection, or positivity threshold) another point that cebo are small in terms of changes in bottom-up nociceptive must be considered is the

Journal

JAMA NeurologyAmerican Medical Association

Published: Jul 20, 2019

References